| Pharmaceutical active ingredients: |
| Betamethasone Dipropionate |
| Available forms, composition and doses of Maxisona: |
| N / A |
| Maxisona medical category: |
| Human:AdrenalsAnti-inflammatory agentsTopical corticosteroidsTopical corticosteroids used as nasal decongestants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07AC01 - BetamethasoneH02AB01 - Betamethasone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| ICN Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Diprotop | Betamethasone Dipropionate | Schering-Plough |
| Disopranil | Betamethasone Dipropionate | Prater Laboratorio |
| Eleuphrat | Betamethasone Dipropionate | Schering-Plough |
| Kuterid | Betamethasone Dipropionate | Sandoz; Lek |
| Labosona | Betamethasone Dipropionate | Labomed Instituto Farmaceutico |
| Maxivate | Betamethasone Dipropionate | Bristol-Myers Squibb |
| Metonate | Betamethasone Dipropionate | Otto Pharmaceutical Industries |
| Occlucort | Betamethasone Dipropionate | Medicis Pharmaceutical Corporation |
| Occlucort Film Forming | Betamethasone Dipropionate | Genderm Corporation |
| Oviskin | Betamethasone Dipropionate | Kalbe Farma |